Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
Clinical trial NCT05665699 · COMPLETED
Trial details
- NCT number
- NCT05665699
- Sponsor
- InventisBio Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2025-07-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.